LRMR
Larimar Therapeutics, Inc. - Common Stock (LRMR)
$85
About Larimar Therapeutics, Inc. - Common Stock (LRMR)
Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Details
Daily high
$3.88
Daily low
$3.78
Price at open
$3.84
52 Week High
$6.42
52 Week Low
$2.72
Market cap
395.6M
Dividend yield
-
Volume
412,140
Avg. volume
1.0M
P/E ratio
-1.91
Larimar Therapeutics, Inc. - Common Stock News
Details
Daily high
$3.88
Daily low
$3.78
Price at open
$3.84
52 Week High
$6.42
52 Week Low
$2.72
Market cap
395.6M
Dividend yield
-
Volume
412,140
Avg. volume
1.0M
P/E ratio
-1.91